Wearable Treatments for Depression & Insomnia: Invest in Fisher Wallace

Click to rate this post!
[Total: 0 Your Rating: 0]

Fisher Wallace’s wearable devices help treat anxiety, depression and insomnia with just 20 minutes’ use per day. The company recently migrated its manufacturing to a high-volume facility, reducing its cost of goods sold (COGS) by 60%. Reasons to invest in Fisher Wallace include:
โ€ข Market Opportunity: The mental health market in the US is expected to exceed $200B in 2020.
โ€ข Effective Products: Fisher Wallace’s device has demonstrated a high effectiveness rate, with most patients experiencing reduced symptoms within a week and less than 1% experiencing side effects.
Forbes has called Fisher Wallace “one of four technologies innovating mental health”. You can invest in Fisher Wallace for as little as $496.80.


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.